OHSU Knight Cancer Institute is one of select few to offer newly approved treatment for blood cancer

Gene transfer therapy, Kymriah, now available for adults with a common form of lymphoma

By Amanda Gibbs July 17, 2018 Portland, Oregon

Downloads

Richard Maziarz, M.D., medical director of the adult blood and marrow stem cell transplant and cellular therapy program at the OHSU Knight Cancer Institute. Researchers in the program are looking for new ways to treat lethal cancers such as skin cancer. (OHSU/Kristyna Wentz-Graff)

Richard Maziarz, M.D.

Richard Maziarz, M.D., medical director of the adult blood and marrow stem cell transplant and cellular therapy program in the OHSU Knight Cancer Institute. (OHSU/Kristyna Wentz-Graff)

Richard Maziarz, M.D.

Richard Maziarz, M.D., medical director of the adult blood and marrow stem cell transplant and cellular therapy program in the OHSU Knight Cancer Institute. (OHSU/Kristyna Wentz-Graff)

Richard Maziarz, M.D. (OHSU)

Richard Maziarz, M.D.

Richard Maziarz, M.D., medical director of the adult blood and marrow stem cell transplant and cellular therapy program in the OHSU Knight Cancer Institute. (OHSU/Kristyna Wentz-Graff)